Resistance to FLT3 inhibitors involves different molecular mechanisms and reduces new DNA synthesisJingmei Yang(Linnaeus University), Ran Friedman(Linnaeus University)Biochemistry and Biophysics ReportsJanuary 16, 202510.1016/j.bbrep.2024.101894Cited by 2SaveCiteExport RISWatch citationsRelated PapersBCR-ABL1 Compound Mutations Combining Key Kinase Domain Positions Confer Clinical Resistance to Ponatinib in Ph Chromosome-Positive Leukemia|Cancer Cell|2014|366Deciphering the molecular mechanism of FLT3 resistance mutations|FEBS Journal|2020|26